- Home
- ALNY vs TRP Comparison
ALNY vs TRP Comparison
Compare ALNY & TRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- TRP
- Stock Information
- Founded
- ALNY 2002
- TRP 1951
- Country
- ALNY United States
- TRP Canada
- Employees
- ALNY N/A
- TRP N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- TRP
- Sector
- ALNY Health Care
- TRP
- Exchange
- ALNY Nasdaq
- TRP Nasdaq
- Market Cap
- ALNY 42.9B
- TRP 49.3B
- IPO Year
- ALNY 2004
- TRP N/A
- Fundamental
- Price
- ALNY $339.80
- TRP $47.02
- Analyst Decision
- ALNY Strong Buy
- TRP Hold
- Analyst Count
- ALNY 25
- TRP 3
- Target Price
- ALNY $347.75
- TRP $62.00
- AVG Volume (30 Days)
- ALNY 878.5K
- TRP 2.3M
- Earning Date
- ALNY 07-31-2025
- TRP 07-31-2025
- Dividend Yield
- ALNY N/A
- TRP 5.33%
- EPS Growth
- ALNY N/A
- TRP 60.55
- EPS
- ALNY N/A
- TRP 2.93
- Revenue
- ALNY $2,348,099,000.00
- TRP $9,660,138,445.00
- Revenue This Year
- ALNY $32.73
- TRP $7.07
- Revenue Next Year
- ALNY $31.50
- TRP $8.92
- P/E Ratio
- ALNY N/A
- TRP $16.02
- Revenue Growth
- ALNY 17.21
- TRP 8.07
- 52 Week Low
- ALNY $205.87
- TRP $41.08
- 52 Week High
- ALNY $345.98
- TRP $51.99
- Technical
- Relative Strength Index (RSI)
- ALNY 66.90
- TRP 41.80
- Support Level
- ALNY $323.74
- TRP $46.61
- Resistance Level
- ALNY $332.19
- TRP $48.20
- Average True Range (ATR)
- ALNY 8.07
- TRP 0.64
- MACD
- ALNY 0.53
- TRP -0.03
- Stochastic Oscillator
- ALNY 83.03
- TRP 17.83
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About TRP TC Energy Corporation
TC Energy operates natural gas, oil, and power generation assets in Canada and the United States. The firm operates more than 60,000 miles of oil and gas pipelines, more than 650 billion cubic feet of natural gas storage, and about 4,300 megawatts of electric power.